Lilly Price Prediction: Case for Double-Digit Upside
Eli Lilly faces a pivotal year as its GLP-1 franchise powers revenue growth and new oral therapies expand addressable...
We break down expense ratios across popular index funds and show how choosing the lowest-cost options can improve long-term retirement outcomes.
28,023 articlesEli Lilly faces a pivotal year as its GLP-1 franchise powers revenue growth and new oral therapies expand addressable...
Meta faced a pivotal near-miss in 2026 as it stepped back from a Kalshi deal. The decision highlights how regulatory ...
Casetlake LP has offered 6.90 per share in cash for EasyJet, valuing the airline around £5.2B, but investors remain d...
Realtor.com’s midyear forecast for 2026 projects slower home price growth and steady mortgage rates, hinting at stron...
Insider moves can be deciphered like a language. This article uses credo's sold 31,290 shares as a practical case stu...
A small board-game importer plans to manufacture Monopoly in the United States after tariffs push production home, a ...
Sirius XM stunned investors with a near-50% rise in the first half of 2026. This analysis breaks down the catalysts, ...
Regulators worldwide are accelerating a shift from perpetual swaps perpetual to regulated perpetual CFDs, reshaping a...
Citadel Advisors remains overweight in Microsoft, neutral on Amazon, and cautious on Apple as AI investment cycles di...
ai healthcare news is accelerating how we diagnose, treat, and manage care. This guide breaks down the trends, how to...
A leading Bundesbank official hints at euro-pegged stablecoins as a tool to reduce dollar dominance. This analysis ex...
Goldman Sachs updated its governance policy to remove formal DEI criteria from director selection, aligning with peer...